DK1682111T3 - Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme - Google Patents

Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme

Info

Publication number
DK1682111T3
DK1682111T3 DK04818113.5T DK04818113T DK1682111T3 DK 1682111 T3 DK1682111 T3 DK 1682111T3 DK 04818113 T DK04818113 T DK 04818113T DK 1682111 T3 DK1682111 T3 DK 1682111T3
Authority
DK
Denmark
Prior art keywords
heart disease
cell therapy
ischemic heart
transcription enhancers
enos transcription
Prior art date
Application number
DK04818113.5T
Other languages
English (en)
Inventor
Andreas Zeiher
Stefanie Dimmeler
Christopher Heeschen
Hartmut Ruetten
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1682111T3 publication Critical patent/DK1682111T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04818113.5T 2003-11-06 2004-10-22 Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme DK1682111T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03025512A EP1529525A1 (en) 2003-11-06 2003-11-06 ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases
PCT/EP2004/011944 WO2005044249A1 (en) 2003-11-06 2004-10-22 Enos transcription enhancers for use in the cell therapy of ischemic heart diseases

Publications (1)

Publication Number Publication Date
DK1682111T3 true DK1682111T3 (da) 2010-04-26

Family

ID=34429288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04818113.5T DK1682111T3 (da) 2003-11-06 2004-10-22 Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme

Country Status (21)

Country Link
EP (3) EP1529525A1 (da)
JP (1) JP4705581B2 (da)
KR (1) KR101133943B1 (da)
CN (1) CN100563643C (da)
AR (1) AR046572A1 (da)
AT (1) ATE454143T1 (da)
AU (1) AU2004286776B2 (da)
BR (1) BRPI0416313A (da)
CA (1) CA2544632C (da)
CY (1) CY1112015T1 (da)
DE (1) DE602004025024D1 (da)
DK (1) DK1682111T3 (da)
ES (1) ES2339252T3 (da)
IL (1) IL174807A (da)
PE (1) PE20050486A1 (da)
PL (1) PL1682111T3 (da)
PT (1) PT1682111E (da)
SI (1) SI1682111T1 (da)
TW (1) TW200528119A (da)
UY (1) UY28605A1 (da)
WO (1) WO2005044249A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1529525A1 (en) 2003-11-06 2005-05-11 Aventis Pharma Deutschland GmbH ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases
AU2006285850A1 (en) 2005-08-29 2007-03-08 Japan Science And Technology Agency Antibody produced using ostrich and method for production thereof
WO2014042292A1 (ko) * 2012-09-12 2014-03-20 연세대학교 산학협력단 단백질 인산화효소 c 활성화제를 포함하는 줄기세포 부착 촉진용 조성물 및 줄기세포의 부착 촉진 방법
GB201601301D0 (en) * 2016-01-25 2016-03-09 Takeda Pharmaceutical Novel compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2368677C (en) * 1999-03-30 2012-07-10 Ran Kornowski Intramyocardial injection of autologous bone marrow
TWI243164B (en) * 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
TWI241190B (en) * 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
MY136316A (en) * 2001-02-13 2008-09-30 Sanofi Aventis Deutschland Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical.
EP1529525A1 (en) 2003-11-06 2005-05-11 Aventis Pharma Deutschland GmbH ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases

Also Published As

Publication number Publication date
CN100563643C (zh) 2009-12-02
ATE454143T1 (de) 2010-01-15
EP2198861B1 (en) 2014-06-25
UY28605A1 (es) 2005-05-31
IL174807A (en) 2011-05-31
BRPI0416313A (pt) 2006-12-26
PE20050486A1 (es) 2005-10-06
WO2005044249A1 (en) 2005-05-19
PL1682111T3 (pl) 2010-06-30
EP2198861A2 (en) 2010-06-23
CY1112015T1 (el) 2015-11-04
CA2544632A1 (en) 2005-05-19
EP1682111A1 (en) 2006-07-26
IL174807A0 (en) 2008-04-13
AU2004286776B2 (en) 2010-05-27
SI1682111T1 (sl) 2010-04-30
KR20060108658A (ko) 2006-10-18
PT1682111E (pt) 2010-02-10
EP1682111B1 (en) 2010-01-06
AR046572A1 (es) 2005-12-14
JP2007509873A (ja) 2007-04-19
KR101133943B1 (ko) 2012-04-13
TW200528119A (en) 2005-09-01
EP2198861A3 (en) 2010-12-15
EP1529525A1 (en) 2005-05-11
CN1878544A (zh) 2006-12-13
AU2004286776A1 (en) 2005-05-19
HK1095527A1 (zh) 2007-05-11
ES2339252T3 (es) 2010-05-18
JP4705581B2 (ja) 2011-06-22
DE602004025024D1 (de) 2010-02-25
CA2544632C (en) 2012-09-04

Similar Documents

Publication Publication Date Title
DE502005007353D1 (de) Zervikale zwischenwirbelprothese
EP1597276A4 (en) Therapeutic molecules
DK2730277T3 (da) Lægemiddelbærer og lægemiddelbærerkit til at inhibere fibrose
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
NO20081572L (no) Pyridazinonderivater anvendt ved smertebehandling
NO20055211D0 (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
DK1919450T3 (da) Antihistamin- og corticosteroidholdig liposomsammensætning og dens anvendelse til fremstilling af et lægemiddel til behandling af rhinitis og beslægtede lidelser
DE602004028934D1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
DK1575951T3 (da) Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
EP1629557A4 (en) Polyimide MATRIX ELEKTROLYT
DK1708994T3 (da) Aryloxyalkylcarbamatderivater, fremstilling og anvendelse herfra inden for terapi
IS8397A (is) Meðferðarfræðilegar bindisameindir
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1597171T3 (da) Terapeutisk mikroskum
IS2736B (is) Makrólíðsamrunaefnasambönd@með@bólgueyðandi@virkni
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
DE602004025444D1 (de) Transdermales therapeutisches System von Gestoden
NO20050689L (no) Terapeutisk anvendelse
DK1594859T3 (da) Indazolamider med analgetisk aktivitet
DK1682111T3 (da) Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme
FR2872694B1 (fr) Instrument medical
DK1771415T3 (da) 2-(1H-indolylsulfanyl)-arylaminderivater til anvendelse i behandlingen af affektive sygdomme, smerte, ADHD og stressinkontinens
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK1598350T3 (da) Pyrrolidin- og thiazolidinforbindelser, fremgangsmåde til fremstilling heraf og deres anvendelse til behandling af hypoglykæmi og diabetes II
DE602005019913D1 (de) Therapeutische pyrazoloä3,4-büpyridine und -indazole